Dopamine Uptake InhibitorsBenztropineNomifensineDopamineCocaineSerotoninNeurotransmitter Uptake InhibitorsDopamine Plasma Membrane Transport ProteinsPiperazinesReceptors, Dopamine D2MazindolDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D1Serotonin Uptake InhibitorsDopamine AgonistsAdrenergic Uptake InhibitorsSerotonin Plasma Membrane Transport ProteinsSerotonin AntagonistsReceptors, SerotoninSynaptosomesReceptors, Dopamine D3Corpus StriatumMembrane Transport ProteinsGABA Uptake InhibitorsTropanesNorepinephrine Plasma Membrane Transport ProteinsReceptor, Serotonin, 5-HT2ARats, Sprague-DawleyNucleus AccumbensFluoxetineReceptor, Serotonin, 5-HT1ADopamine AgentsDose-Response Relationship, DrugZimeldineMethamphetamineDesipramineNipecotic AcidsMicrodialysisNerve Tissue ProteinsNeostriatumNorepinephrineReceptor, Serotonin, 5-HT2CBehavior, AnimalMembrane GlycoproteinsMotor ActivitySerotonin AgentsBiogenic MonoaminesReceptors, Dopamine D5AmphetamineReceptors, Serotonin, 5-HT2Receptor, Serotonin, 5-HT2BSerotonin Receptor AgonistsLobelineCaudate NucleusReceptor, Serotonin, 5-HT1BMethylphenidateVesicular Monoamine Transport ProteinsClomipramineBiological TransportDrug InteractionsParoxetineMembrane Transport ModulatorsBrainDopamine beta-HydroxylaseCitalopramFenfluramineReceptors, Serotonin, 5-HT1PargylineTetrabenazineSerotonin 5-HT2 Receptor AntagonistsNeuronsMesencephalonSerotonin SyndromeAmphetaminesCarrier ProteinsMetergolineStereotyped BehaviorFluvoxamineSubstantia NigraCocaine-Related DisordersReserpineImipramineProtriptylineN-Methyl-3,4-methylenedioxyamphetamineBrain ChemistrySerotonin 5-HT2 Receptor AgonistsReceptors, Serotonin, 5-HT3Binding, CompetitiveQuipazineMonoamine Oxidase Inhibitors1-Methyl-4-phenylpyridiniumTritium3,4-Dihydroxyphenylacetic AcidSelf AdministrationKineticsQuinpiroleTime FactorsTryptophan HydroxylaseBenzazepines